 Kidney Neoplasms
"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
| Descriptor ID |
D007680
|
| MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
| Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 2 | 0 | 2 | | 1999 | 2 | 0 | 2 | | 2000 | 3 | 0 | 3 | | 2001 | 3 | 0 | 3 | | 2003 | 1 | 0 | 1 | | 2004 | 4 | 0 | 4 | | 2006 | 2 | 0 | 2 | | 2007 | 5 | 0 | 5 | | 2008 | 4 | 2 | 6 | | 2009 | 4 | 3 | 7 | | 2010 | 6 | 2 | 8 | | 2011 | 8 | 1 | 9 | | 2012 | 11 | 0 | 11 | | 2013 | 11 | 3 | 14 | | 2014 | 16 | 1 | 17 | | 2015 | 9 | 0 | 9 | | 2016 | 8 | 0 | 8 | | 2017 | 14 | 2 | 16 | | 2018 | 16 | 1 | 17 | | 2019 | 25 | 0 | 25 | | 2020 | 16 | 0 | 16 | | 2021 | 20 | 1 | 21 | | 2022 | 21 | 0 | 21 | | 2023 | 17 | 0 | 17 | | 2024 | 22 | 1 | 23 | | 2025 | 27 | 0 | 27 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
Shah NJ, Sura S, Shinde R, Dai W, Wentworth C, Conkling P, Bupathi M, Vickery D, Perini R, Motzer RJ. Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post immune-oncology and vascular endothelial growth factor receptor targeted therapies: A multicenter community oncology-based study. Urol Oncol. 2026 Apr; 44(4):110979.
-
Kopp RM, Massari F, Grande E, Schieber TJ, Ürün Y, Kopecký J, Molina-Cerrillo J, Basso U, Kucharz J, Büttner T, Pichler R, Fiala O, Myint ZW, Galli L, Buchler T, Rizzo M, Bolek H, Bourlon MT, Conteduca V, Pinto A, Rizzo A, Rosellini M, Roviello G, Zgura A, Mollica V, Partl A, Yildirim A, Akova U, Buti S, Monteiro FSM, Soares A, Porta C, Bilen MA, Li H, Santoni M. Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study. Cancer Immunol Immunother. 2025 Nov 14; 74(12):374.
-
Velasquez-Herrera T, Valverde P, Fuentes S, Peña A, Ortiz R, Calderon P, Montero M, Gattuso G, Blanco J, Arreola M, Fernandez-Pineda I, Metzger M, Luna-Fineman S, Wilimas J, Spreafico F. Second Generation of AHOPCA (Asociación de Hemato-Oncología Pediátrica de Centro América) Treatment Guidelines for Wilms Tumor: A Report of Outcomes. Pediatr Blood Cancer. 2026 Feb; 73(2):e32148.
-
Molina-Cerrillo J, Roviello G, Bourlon MT, Studentova H, Fiala O, Cerbone L, Kucharz J, Ansari J, Zeppellini A, Taha T, Buti S, Ürün Y, Scagliarini S, Li H, Sunela K, Park SH, Rizzo M, Zgura A, Chiari R, Seront E, Catalano M, Ghosn M, Filosa A, Soares A, Massari F, Monteiro FSM, Grande E, Porta C, Bracarda S, Santoni M. Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study). Int J Cancer. 2026 Mar 01; 158(5):1396-1405.
-
Massari F, Rosellini M, Melichar B, Grande E, Bourlon MT, Li H, Fiala O, Park SH, Fita MJJ, Taha T, Molina-Cerrillo J, Santini D, de Liañ AG, Büttner T, Scagliarini S, Manneh Kopp R, Zeppellini A, Ghosn M, Conteduca V, Bölek H, Rizzo A, Ansari J, Mollica V, Zgura A, Filosa A, Yildirim A, Akova U, Monteiro FSM, Buti S, Soares A, Bilen MA, Ürün Y, Santoni M. Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study. JCO Glob Oncol. 2025 Oct; 11:e2500376.
-
Dabbas MR, Guer M, Musso G, Garofano G, Meagher MF, Puri D, Yuen KL, Capitanio U, Larcher A, Saitta C, Kim B, Karamcheti S, Baker BH, Saito K, Yasuda Y, Patil D, Briganti A, Salonia A, Fujii Y, Master V, Montorsi F, Derweesh IH. Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter Analysis. Clin Genitourin Cancer. 2026 Feb; 24(1):102460.
-
Garofano G, Saitta C, Musso G, Meagher MF, Capitanio U, Puri D, Dabbas M, Birouty N, Karamcheti S, Kim B, Yuen KL, Larcher A, Baker B, Autorino R, Pandolfo SD, Montorsi F, Saita A, Lazzeri M, Lughezzani G, Casale P, Buffi NM, Derweesh IH. Rising Trends of Aggressive Renal Cell Carcinoma Among Younger Adults: Insights From the National Cancer Database. Clin Genitourin Cancer. 2025 Dec; 23(6):102425.
-
Musso G, Garofano G, Dabbas M, Meagher MF, Yuen KL, Birouty N, Baker B, Saitta C, Guer M, Montorsi F, Briganti A, Capitanio U, Larcher A, Salonia A, Derweesh IH. The Influence of Lymphovascular Invasion on T Stage Upstaging and Overall Survival in Renal Cell Carcinoma: A Population-Based Study. Clin Genitourin Cancer. 2025 Oct; 23(5):102412.
-
Groisser A, Frantz A, Geller JI, Ortiz MV, Walterhouse D, Ranalli M, Woods-Swafford W, Schoettler P, Garrington T, Mullen EA, Ash S, Bardhan P, Balis F, Dome JS. Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms Tumor. Pediatr Blood Cancer. 2025 Oct; 72(10):e31915.
-
Musso G, Birouty N, Salonia A, Garofano G, Dabbas M, Meagher MF, Yuen KL, Baker B, Saitta C, Patil D, Tanaka H, Kobayashi M, Fukuda S, Montorsi F, Briganti A, Capitanio U, Larcher A, Rosiello G, Fujii Y, Master VA, Derweesh IH. Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling. Urology. 2025 Nov; 205:99-107.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|